Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verena Moos

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Journal of Clinical Microbiology|August 23, 2013
Validation of an rpoB gene PCR assay for detection of Tropheryma whipplei: 10 years' experience in a National Reference LaboratoryAnnette Moter, Dinah Schmiedel, Annett Petrich, et al.
The Journal of Infectious Diseases|October 18, 2013
Macrophages accumulate in the gut mucosa of untreated HIV-infected patientsKristina Allers, Mira Fehr, Kristina Conrad, et al.
The Journal of Infectious Diseases|September 17, 2011
Modulation of the CD4+ T-cell response by Helicobacter pylori depends on known virulence factors and bacterial cholesterol and cholesterol α-glucoside contentMacarena Beigier-Bompadre, Verena Moos, Elena Belogolova, et al.
Clinical and Vaccine Immunology : CVI|October 23, 2015
Specific CD4+ T-Cell Reactivity and Cytokine Release in Different Clinical Presentations of LeptospirosisMagdalena Sarah Volz, Verena Moos, Kristina Allers, et al.
Scientific Reports|July 4, 2020
The colonic mucosa-associated microbiome in SIV infection: shift towards Bacteroidetes coincides with mucosal CD4<sup>+</sup> T cell depletion and enterocyte damageKristina Allers, Christiane Stahl-Hennig, Tomas Fiedler, et al.
European Journal of Microbiology & Immunology|December 17, 2016
Usage of Murine T-cell Hybridoma Cells as Responder Cells Reveals Interference of <i>Helicobacter Pylori</i> with Human Dendritic Cell-mediated Antigen PresentationMichael Fehlings, Lea Drobbe, Macarena Beigier-Bompadre, et al.
The Lancet. Infectious Diseases|February 20, 2025
Oral treatment of Whipple's disease with doxycycline and hydroxychloroquine versus intravenous therapy with ceftriaxone followed by oral trimethoprim-sulfamethoxazole in Germany: a phase 2/3, prospective, open-label, randomised, controlled, non-inferiority trialVerena Moos, Justina Krüger, Kristina Allers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 16, 2011
Regulatory T cells in patients with Whipple's diseaseKatina Schinnerling, Verena Moos, Anika Geelhaar, et al.
Neuromuscular Disorders : NMD|December 10, 2013
Inflammatory myopathy with abundant macrophages (IMAM): the immunology revisitedJan Leo Rinnenthal, Hans-Hilmar Goebel, Corinna Preuße, et al.
Toxins|November 24, 2023
A Colonic Organoid Model Challenged with the Large Toxins of <i>Clostridioides difficile</i> TcdA and TcdB Exhibit Deregulated Tight Junction ProteinsMartina Schneemann, Lucas Heils, Verena Moos, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Journal of Clinical Microbiology|August 23, 2013
Validation of an rpoB gene PCR assay for detection of Tropheryma whipplei: 10 years' experience in a National Reference LaboratoryAnnette Moter, Dinah Schmiedel, Annett Petrich, et al.
The Journal of Infectious Diseases|October 18, 2013
Macrophages accumulate in the gut mucosa of untreated HIV-infected patientsKristina Allers, Mira Fehr, Kristina Conrad, et al.
The Journal of Infectious Diseases|September 17, 2011
Modulation of the CD4+ T-cell response by Helicobacter pylori depends on known virulence factors and bacterial cholesterol and cholesterol α-glucoside contentMacarena Beigier-Bompadre, Verena Moos, Elena Belogolova, et al.
Clinical and Vaccine Immunology : CVI|October 23, 2015
Specific CD4+ T-Cell Reactivity and Cytokine Release in Different Clinical Presentations of LeptospirosisMagdalena Sarah Volz, Verena Moos, Kristina Allers, et al.
Scientific Reports|July 4, 2020
The colonic mucosa-associated microbiome in SIV infection: shift towards Bacteroidetes coincides with mucosal CD4<sup>+</sup> T cell depletion and enterocyte damageKristina Allers, Christiane Stahl-Hennig, Tomas Fiedler, et al.
European Journal of Microbiology & Immunology|December 17, 2016
Usage of Murine T-cell Hybridoma Cells as Responder Cells Reveals Interference of <i>Helicobacter Pylori</i> with Human Dendritic Cell-mediated Antigen PresentationMichael Fehlings, Lea Drobbe, Macarena Beigier-Bompadre, et al.
The Lancet. Infectious Diseases|February 20, 2025
Oral treatment of Whipple's disease with doxycycline and hydroxychloroquine versus intravenous therapy with ceftriaxone followed by oral trimethoprim-sulfamethoxazole in Germany: a phase 2/3, prospective, open-label, randomised, controlled, non-inferiority trialVerena Moos, Justina Krüger, Kristina Allers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 16, 2011
Regulatory T cells in patients with Whipple's diseaseKatina Schinnerling, Verena Moos, Anika Geelhaar, et al.
Neuromuscular Disorders : NMD|December 10, 2013
Inflammatory myopathy with abundant macrophages (IMAM): the immunology revisitedJan Leo Rinnenthal, Hans-Hilmar Goebel, Corinna Preuße, et al.
Toxins|November 24, 2023
A Colonic Organoid Model Challenged with the Large Toxins of <i>Clostridioides difficile</i> TcdA and TcdB Exhibit Deregulated Tight Junction ProteinsMartina Schneemann, Lucas Heils, Verena Moos, et al.
Pageof 8